发明名称 ANTIVIRAL JAK INHIBITORS USEFUL IN TREATING OR PREVENTING RETROVIRAL AND OTHER VIRAL INFECTIONS
摘要 Compounds, compositions, and methods of treatment and prevention of HIV infection are disclosed. The compounds are pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidine JAK inhibitors. Combinations of these JAK inhibitors and additional antiretroviral compounds, such as NRTI, NNRTI, integrase inhibitors, entry inhibitors, protease inhibitors, and the like, are also disclosed. In one embodiment, the combinations include a combination of adenine, cytosine, thymidine, and guanine nucleoside antiviral agents, optionally in further combination with at least one additional antiviral agent that works via a different mechanism than a nucleoside analog. This combination has the potential to eliminate the presence of HIV in an infected patient.
申请公布号 US2016051554(A1) 申请公布日期 2016.02.25
申请号 US201514808860 申请日期 2015.07.24
申请人 EMORY UNIVERSITY 发明人 Gavegnano Christina;Schinazi Raymond F.
分类号 A61K31/519;A61K45/06 主分类号 A61K31/519
代理机构 代理人
主权项 1. A method for treating an HIV infection, comprising administering to a patient in need thereof an effective antiviral amount of a JAK inhibitor selected from the group consisting of Jakafi, having the formula: Tofacitinib, having the formula: And Baricitinib, having the formula:or a pharmaceutically acceptable salt thereof.
地址 Atlanta GA US